Published in EMBO J on July 01, 1988
Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol (1990) 3.20
IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. Nature (2014) 2.12
IgG subclasses and allotypes: from structure to effector functions. Front Immunol (2014) 1.95
IgG4 breaking the rules. Immunology (2002) 1.93
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J Clin Microbiol (2001) 1.70
Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. J Virol (2002) 1.52
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother (1994) 1.48
Nanosecond fluorescence microscopy. Emission kinetics of fura-2 in single cells. Biophys J (1991) 1.41
Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse. Biotechnol Bioeng (2009) 1.33
Immunoglobulin G3 from polyclonal human immunodeficiency virus (HIV) immune globulin is more potent than other subclasses in neutralizing HIV type 1. J Virol (2001) 1.29
Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions. MAbs (2011) 1.27
Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins. Proc Natl Acad Sci U S A (1990) 1.26
Characterization of anticapsular monoclonal antibodies that regulate activation of the complement system by the Cryptococcus neoformans capsule. Infect Immun (1998) 1.19
The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain. J Exp Med (1991) 1.12
IgG subclass and heavy chain domains contribute to binding and protection by mAbs to the poly γ-D-glutamic acid capsular antigen of Bacillus anthracis. PLoS Pathog (2013) 1.06
Generation and characterization of hybridoma antibodies for immunotherapy of tularemia. Immunol Lett (2007) 1.06
Continual low-level activation of the classical complement pathway. J Exp Med (2001) 1.06
Human constant regions influence the antibody binding characteristics of mouse-human chimeric IgG subclasses. Immunology (1996) 1.05
Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies. J Immunol (2008) 1.04
Mutational analysis of the cellular receptor for poliovirus. J Virol (1991) 1.04
Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen. J Exp Med (1988) 1.03
MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4. Proc Natl Acad Sci U S A (2013) 1.02
Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Infect Immun (1992) 1.01
'Sticky feet'-directed mutagenesis and its application to swapping antibody domains. Nucleic Acids Res (1989) 1.01
Transferrin-antibody fusion proteins are effective in brain targeting. Proc Natl Acad Sci U S A (1995) 0.98
Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo. Clin Exp Immunol (2002) 0.97
Using empirical phase diagrams to understand the role of intramolecular dynamics in immunoglobulin G stability. J Pharm Sci (2009) 0.92
A 24,000 MW Trypanosoma cruzi antigen is a B-cell activator. Immunology (1998) 0.91
Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7/8 agonists in macaques. PLoS One (2011) 0.91
The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection. Trends Mol Med (2015) 0.90
Probing antibody internal dynamics with fluorescence anisotropy and molecular dynamics simulations. MAbs (2013) 0.89
Expression of 12 rabbit IgA C alpha genes as chimeric rabbit-mouse IgA antibodies. Proc Natl Acad Sci U S A (1989) 0.88
Constant domains influence binding of mouse-human chimeric antibodies to the capsular polypeptide of Bacillus anthracis. Virulence (2013) 0.88
Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3). Mol Cell Proteomics (2015) 0.88
Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation. Biophys J (2007) 0.87
Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens. Vaccine (2007) 0.87
B1b cells recognize protective antigens after natural infection and vaccination. Front Immunol (2014) 0.86
The structure of dual-variable-domain immunoglobulin molecules alone and bound to antigen. MAbs (2013) 0.85
Activation of complement by human IgG1 and human IgG3 antibodies against the human leucocyte antigen CD52. Immunology (1998) 0.84
Antibody-cytokine fusion proteins: applications in cancer therapy. Expert Opin Biol Ther (2008) 0.84
One disulfide bond in front of the second heavy chain constant region is necessary and sufficient for effector functions of human IgG3 without a genetic hinge. Proc Natl Acad Sci U S A (1994) 0.83
CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaques. J Med Primatol (2011) 0.82
Hematopoietic properties of granulocyte colony-stimulating factor/immunoglobulin (G-CSF/IgG-Fc) fusion proteins in normal and neutropenic rodents. PLoS One (2014) 0.82
Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis. Immunology (2001) 0.82
Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis. Infect Immun (2000) 0.82
The binding sites of monoclonal antibodies to the non-reducing end of Francisella tularensis O-antigen accommodate mainly the terminal saccharide. Immunology (2013) 0.82
Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: potential applications for cellular targeting. Proc Natl Acad Sci U S A (1990) 0.81
The solution structures of two human IgG1 antibodies show conformational stability and accommodate their C1q and FcγR ligands. J Biol Chem (2015) 0.81
Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein. Proc Natl Acad Sci U S A (1995) 0.80
Cytotoxicity of alpha-particle-emitting astatine-211-labelled antibody in tumour spheroids: no effect of hyperthermia. Br J Cancer (1998) 0.79
Bivalency is required for anticapsular monoclonal antibodies to optimally suppress activation of the alternative complement pathway by the Cryptococcus neoformans capsule. Infect Immun (1998) 0.79
Antibody Subclass Repertoire and Graft Outcome Following Solid Organ Transplantation. Front Immunol (2016) 0.78
Agglutinating mouse IgG3 compares favourably with IgMs in typing of the blood group B antigen: Functionality and stability studies. Sci Rep (2016) 0.78
Three-dimensional structure of the human myeloma IgG2. PLoS One (2013) 0.78
A human anti-Pseudomonas aeruginosa serotype O6ad immunoglobulin G1 expressed in transgenic tobacco is capable of recruiting immune system effector function in vitro. Antimicrob Agents Chemother (2007) 0.77
Nodular glomerulosclerosis with anti-glomerular basement membrane-like glomerulonephritis; a distinct pattern of kidney injury observed in smokers. Clin Kidney J (2014) 0.76
Understanding the relationship between biotherapeutic protein stability and solid-liquid interfacial shear in constant region mutants of IgG1 and IgG4. J Pharm Sci (2013) 0.76
Our NIH years: a confluence of beginnings. J Biol Chem (2012) 0.75
Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1. Mol Immunol (2015) 0.75
Minimizing the risk of allo-sensitization to optimize the benefit of allogeneic cardiac-derived stem/progenitor cells. Sci Rep (2017) 0.75
Influence of IgG Subclass on Human Antimannan Antibody-Mediated Resistance to Hematogenously Disseminated Candidiasis in Mice. Infect Immun (2015) 0.75
Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro. PLoS One (2015) 0.75
Effector attenuating substitutions that maintain antibody stability and reduce toxicity in mice. J Biol Chem (2017) 0.75
Investigating Structure and Dynamics of Proteins in Amorphous Phases Using Neutron Scattering. Comput Struct Biotechnol J (2016) 0.75
Antibody organization on lipid films. Influence of pH and interchain disulphide reduction. Biochem J (1990) 0.75
Profile of jeffery L. Dangl. Proc Natl Acad Sci U S A (2010) 0.75
IgG1 Is Required for Optimal Protection after Immunization with the Purified Porin OmpD from Salmonella Typhimurium. J Immunol (2017) 0.75
Cloning and complete nucleotide sequence of mouse immunoglobulin gamma 1 chain gene. Cell (1979) 5.04
Three-dimensional structure of immunoglobulins. Annu Rev Biochem (1979) 3.66
Electron microscopy of an antibody-hapten complex. J Mol Biol (1967) 3.63
Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A (1979) 3.46
Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. J Mol Biol (1980) 3.25
Immunoglobulin G: functional sites. Mol Immunol (1985) 3.12
Crystallographic structure studies of an IgG molecule and an Fc fragment. Nature (1976) 3.00
Complete nucleotide sequence of immunoglobulin gamma2b chain gene cloned from newborn nouse DNA. Nature (1980) 2.97
Segmental flexibility in an antibody molecule. J Mol Biol (1970) 2.92
Structure of the constant and 3' untranslated regions of the murine Balb/c gamma 2a heavy chain messenger RNA. Nucleic Acids Res (1980) 2.37
Biological significance of carbohydrate chains on monoclonal antibodies. Proc Natl Acad Sci U S A (1983) 2.33
Three-dimensional structure of an intact human immunoglobulin. Proc Natl Acad Sci U S A (1977) 2.23
Correlation between segmental flexibility and effector function of antibodies. Nature (1984) 2.22
GROSS CONFORMATION OF RABBIT 7 S GAMMA-IMMUNOGLOBULIN AND ITS PAPAIN-CLEAVED FRAGMENTS. J Biol Chem (1965) 2.21
The nucleotide sequence of a human immunoglobulin C gamma1 gene. Nucleic Acids Res (1982) 2.20
Effect of tunicamycin on IgM, IgA, and IgG secretion by mouse plasmacytoma cells. J Immunol (1978) 2.17
Activation of mouse complement by monoclonal mouse antibodies. Eur J Immunol (1981) 2.11
Linkage and sequence homology of two human immunoglobulin gamma heavy chain constant region genes. Proc Natl Acad Sci U S A (1982) 1.93
Structure and function of the constant regions of immunoglobulins. Q Rev Biophys (1976) 1.91
MOLECULAR MECHANISM OF FORMATION OF AN ANTIGEN-ANTIBODY COMPLEX. Nature (1965) 1.90
Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor. Mol Immunol (1985) 1.68
Comparison of the hinge-coding segments in human immunoglobulin gamma heavy chain genes and the linkage of the gamma 2 and gamma 4 subclass genes. EMBO J (1982) 1.47
Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc Natl Acad Sci U S A (1981) 1.41
Rapid isolation of cloned isotype switch variants using fluorescence activated cell sorting. Cytometry (1982) 1.32
Structural analysis of the murine IgG3 constant region gene. EMBO J (1984) 1.30
Rotational dynamics of monoclonal anti-dansyl immunoglobulins. J Mol Biol (1982) 1.20
Transfer and expression of immunoglobulin genes. Annu Rev Immunol (1984) 1.15
The structural basis for the functional versatility of immunoglobulin G1. Can J Biochem (1978) 1.12
Segmental flexibility of immunoglobulin G antibody molecules in solution: a new interpretation. Biochemistry (1981) 1.01
Molecular genetic analysis of genes encoding the heavy chains of rabbit IgG. J Immunol (1984) 0.83
Proton nuclear magnetic resonance study on the dynamics of the conformation of the hinge segment of human G1 immunoglobulin. Biochemistry (1985) 0.82
A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol (1973) 45.44
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86
Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev (1979) 16.45
Light-directed, spatially addressable parallel chemical synthesis. Science (1991) 15.09
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. Curr Top Microbiol Immunol (1978) 13.40
Energy transfer: a spectroscopic ruler. Proc Natl Acad Sci U S A (1967) 11.78
Fluorescence energy transfer as a spectroscopic ruler. Annu Rev Biochem (1978) 11.41
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells. Proc Natl Acad Sci U S A (1997) 8.35
The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites. J Mol Biol (1965) 7.87
Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A (1988) 7.76
Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man. J Exp Med (1981) 6.82
Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science (1992) 6.72
T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views. J Exp Med (1980) 6.62
A new I subregion (I-J) marked by a locus (Ia-4) controlling surface determinants on suppressor T lymphocytes. J Exp Med (1976) 6.11
Cyclic GMP cascade of vision. Annu Rev Neurosci (1986) 6.06
The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med (1983) 5.74
G proteins: a family of signal transducers. Annu Rev Cell Biol (1986) 5.38
Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A (1983) 5.18
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies. Proc Natl Acad Sci U S A (1984) 5.15
T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11
Statistical distributions of nucleosomes: nonrandom locations by a stochastic mechanism. Nucleic Acids Res (1988) 4.92
Flow of information in the light-triggered cyclic nucleotide cascade of vision. Proc Natl Acad Sci U S A (1981) 4.87
Fluorescence activated cell sorting. Rev Sci Instrum (1972) 4.81
Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A (1990) 4.61
Defective B cell development and function in Btk-deficient mice. Immunity (1995) 4.20
Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J Exp Med (1985) 4.16
Surface density determination in membranes by fluorescence energy transfer. Biochemistry (1978) 4.13
Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Genes Dev (1990) 3.98
CD8 naive T cell counts decrease progressively in HIV-infected adults. J Clin Invest (1995) 3.97
Fluorescence spectroscopy of proteins. Science (1968) 3.96
11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med (2001) 3.94
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 3.89
Origin of murine B cell lineages. Annu Rev Immunol (1993) 3.82
Demonstration that antigen-binding cells are precursors of antibody-producing cells after purification with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A (1972) 3.77
Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci U S A (1990) 3.70
Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med (2001) 3.69
The Ly-1 B cell lineage. Immunol Rev (1986) 3.59
Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A (1979) 3.46
Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. J Biol Chem (1969) 3.39
Highly cooperative feedback control of retinal rod guanylate cyclase by calcium ions. Nature (1988) 3.37
Molecular mechanics of calcium-myristoyl switches. Nature (1997) 3.36
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 3.32
The dimeric nature of the gramicidin A transmembrane channel: conductance and fluorescence energy transfer studies of hybrid channels. J Mol Biol (1977) 3.27
Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science (1991) 3.27
Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science (1992) 3.26
Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24
Identification and separation of pre T-cells from nu/nu mice: differentiation by preculture with thymic reticuloepithelial cells. Cell Immunol (1976) 3.17
Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1. Nature (2000) 3.11
Highly cooperative opening of calcium channels by inositol 1,4,5-trisphosphate. Science (1988) 3.07
Calcium spiking. Annu Rev Biophys Biophys Chem (1991) 3.06
Subnanosecond motions of tryptophan residues in proteins. Proc Natl Acad Sci U S A (1979) 3.06
A spin-labeled hapten. Proc Natl Acad Sci U S A (1965) 3.02
Active suppression of immunoglobulin allotype synthesis. I. Chronic suppression after perinatal exposure to maternal antibody to paternal allotype in (SJL x BALB-c)F 1 mice. J Exp Med (1972) 3.02
Molecular model for receptor-stimulated calcium spiking. Proc Natl Acad Sci U S A (1988) 3.00
Photolyzed rhodopsin catalyzes the exchange of GTP for bound GDP in retinal rod outer segments. Proc Natl Acad Sci U S A (1980) 3.00
Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron (1994) 3.00
Gene transfer and molecular cloning of the rat nerve growth factor receptor. Nature (1987) 2.98
Selective expression of H-2 (i-region) loci controlling determinants on helper and suppressor T lymphocytes. J Exp Med (1976) 2.94
Segmental flexibility in an antibody molecule. J Mol Biol (1970) 2.92
The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes. EMBO J (1990) 2.74
Fluorescent phycobiliprotein conjugates for analyses of cells and molecules. J Cell Biol (1982) 2.73
Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. Science (1985) 2.68
Retinal has a highly dipolar vertically excited singlet state: implications for vision. Proc Natl Acad Sci U S A (1976) 2.68
Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system. Proc Natl Acad Sci U S A (1999) 2.63
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Memory B cells at successive stages of differentiation. Affinity maturation and the role of IgD receptors. J Exp Med (1980) 2.58
Active suppression of immunoglobulin allotype synthesis. 3. Identification of T cells as responsible for suppression by cells from spleen, thymus, lymph node, and bone marrow. J Exp Med (1973) 2.57
Single-molecule fluorescence detection: autocorrelation criterion and experimental realization with phycoerythrin. Proc Natl Acad Sci U S A (1989) 2.55
Localization of murine Ig-1b and Ig-1a (IgG 2a) allotypic determinants detected with monoclonal antibodies. Mol Immunol (1979) 2.55
Gating kinetics of the cyclic-GMP-activated channel of retinal rods: flash photolysis and voltage-jump studies. Proc Natl Acad Sci U S A (1988) 2.53
Gramicidin A crystals contain two cation binding sites per channel. Nature (1979) 2.53
Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci U S A (1990) 2.52
Fetal cells in the blood of pregnant women: detection and enrichment by fluorescence-activated cell sorting. Proc Natl Acad Sci U S A (1979) 2.45